HGH Fragment 176-191 – 5mg | Lipolytic Research Compound

HGH Fragment 176-191 is a synthetic research compound corresponding to the C-terminal region of the human growth hormone molecule. It provides a laboratory model for investigating the molecular characteristics and signaling activity associated with this specific HGH-derived sequence.

Key Research Areas:

• HGH Fragment Research — Laboratory characterization of the molecular properties of the 176-191 sequence.
• Molecular Signaling Research — Investigation of signaling pathways associated with HGH Fragment 176-191.
• Structure-Activity Research — Laboratory investigation of relationships between the fragment’s amino-acid sequence and its molecular activity.
• Cellular Signaling Research — Investigation of cellular signaling processes associated with the compound.
• Comparative Compound Research — Laboratory comparison of HGH Fragment 176-191 with related HGH-derived research compounds.

Product Specifications:

• C-terminal fragment corresponding to HGH amino acids 176-191
• 5mg lyophilized powder per vial
• ≥99% purity via HPLC and mass spectrometry
• Third-party COA available
• Store according to applicable laboratory storage requirements and protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic. Not FDA-approved.